跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-LENALIDOMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-LENALIDOMIDE
Authorized
STANDARD
TARO-LENALIDOMIDE
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
755db0319082b7cc
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
755db0319082b7cc
Drug Approval Canada Name
TARO-LENALIDOMIDE
Product Name
TARO-LENALIDOMIDE
Status
Marketed
Status Date
2022-06-13
Original Market Date
2022-06-13
Din
02507897
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L04AX04 LENALIDOMIDE
Atc Name
l 04 ax 04
Aig Number
0152422003
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive, Brampton, Ontario, Canada, L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
LENALIDOMIDE
15 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
755db0319082b7cc
Type
Standard
Back to Health Canada Approvals